Innovations In The Therapeutic Paradigm Of Cell Therapy

What is the curative potential of protein design? In the latest episode of Biorasi's Few & Far Between podcast, Marc Lajoie, CEO at Outpace Bio, discusses how de novo proteins can be used to reprogram immune cells. During this discussion, Lajorie explains how de novo proteins can be used to reprogram immune cells. Protein design allowed Lajorie and his team to overcome evolutionary constraints by intentionally redesigning protein backbones, enabling greater control over their function, which led to the founding of Outpace to scale these advancements. Learn more about his work and the advancements being made in protein therapeutics by listening to this full interview.